Pfizer’s Epoetin Alfa Biosimilar Approved by FDA

Pfizer’s Epoetin Alfa Biosimilar Approved by FDA

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration (FDA) on Tuesday approved the first biosimilar to Amgen’s blockbuster Epogen/Procrit (epoetin alfa), bringing the total number of biosimilars approved by the agency to 10.